Japan Alopecia Market Size, Share, and COVID-19 Impact Analysis, By Disease Type (Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia, and Others), By Treatment (Pharmaceuticals, Oral, and Devices), and Japan Alopecia Market Insights, Industry Trend, Forecasts to 2035

Japan Alopecia Market Insights Forecasts to 2035

• The Japan Alopecia Market Size is Expected to Grow at a CAGR of around 7.2% from 2025 to 2035
• The Japan Alopecia Market Size is Expected to Hold a Significant Share by 2035

According to a Research Report Published by Spherical Insights & Consulting, The Japan Alopecia Market Size is anticipated to Hold a Significant Share by 2035, Growing at a CAGR of 7.2% from 2025 to 2035. The Japanese alopecia market is driven by various factors, including rising awareness regarding alopecia treatment, rising hair loss prevalence, rising demand for effective treatment, and advancements in pharmaceutical formulations.

Market Overview

Alopecia refers to the loss of partial or complete hair from body areas where hair normally occurs, usually the scalp. It includes various types such as alopecia areata, cicatricial, traction, and androgenetic alopecia. The Japan alopecia market is a market for products and services used to manage or treat alopecia in Japan. Treatment includes pharmaceutical drugs, oral supplements, topical therapies, and medical devices. Japan has one of the highest aging populations globally, which leads to a higher prevalence of alopecia, which further creates the demand for effective treatments for alopecia is one of the key driving factors for this market. Increased work-related stress, poor nutrition, and changing lifestyles contributed to the hair loss conditions, which further boost the market for alopecia. The growing demand for personalized medicines is a key trend in this market. The rising popularity of herbal and natural remedies presents an opportunity for product development by using natural ingredients.

Report Coverage

This research report categorizes the market for the Japan alopecia market based on various segments and regions, and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan alopecia market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Japan alopecia market.

Driving Factors

The Japan alopecia market is witnessing steady growth owing to several factors. Japan's alopecia rate is comparatively high at 1.5%–2%, and approximately 25% of males are afflicted by middle age. Stress, diet, age, and environment are all speeding up hair loss, which further fuels demand for treatment. The advancement in technology of drugs such as targeted drugs (e.g., JAK inhibitors, Baricitinib) and the technology of less invasive surgeries, such as FUE hair transplants, are improving the effectiveness of treatments. Moreover, the increased application of PRP and low-level laser therapy is also propelling the growth of the market. Additionally, people are becoming aware of the importance of appearance and personal grooming, which plays a crucial role in the expansion of the market.

Restraining Factors

One of the notable restraints is the high cost of treatment, which is unaffordable for price-sensitive consumers. Additionally, many Japanese depend upon National Health Insurance, which usually does not cover new medications like JAK inhibitors. Thus, patients without full coverage pay very high out-of-pocket expenses for drugs, procedures, and specialist visits, which further limit the market expansion.

Market Segmentation

The Japan alopecia market share is classified into disease type and treatment.

• The alopecia areata segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The Japan alopecia market is segmented by disease type into alopecia areata, cicatricial, traction, and androgenetic alopecia. Among these, the alopecia areata segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This segmental growth is attributed to the increasing prevalence of diseases. Additionally, people are becoming aware of the disease.  

• The pharmaceuticals segment held the dominant share in 2024 and is expected to grow at a substantial CAGR during the forecast period.

The Japan alopecia market is segmented by treatment into pharmaceuticals, oral, and devices. Among these, the pharmaceuticals segment held the dominant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. This segmental growth is attributed to affordability of pharmaceutical products and high usage of prescription and OTC drugs. Additionally, product innovation and R&D play a crucial role in segmental growth.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Japan alopecia market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Sun Pharmaceutical Industries Ltd.
• Taisho Pharmaceutical
• Shiseido Co., Ltd.
• Kao Corporation
• Rohto Pharmaceutical Co., Ltd.
• Mandom Corporation
• Lion Corporation
• Hoyu Co., Ltd.
• Milbon Co., Ltd.
• Pola Orbis Holdings Inc.
• Kracie Holdings, Ltd.
• NatureLab Co., Ltd.
• Arimino Co., Ltd.
• DARIYA Co., Ltd.
• Other

Recent Developments

• In June 2022, Baricitinib (Olumiant) received marketing approval in Japan for the treatment of alopecia areata.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan alopecia market based on the below-mentioned segments:

Japan Alopecia Market, By Disease Type

• Alopecia Areata
• Cicatricial
• Traction
• Androgenetic Alopecia

Japan Alopecia Market, By Treatment

• Pharmaceuticals
• Oral
• Devices